| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
SB 269970 hydrochloride manufacturers
- SB-269970
-
- $3500.00
-
2026-05-22
- CAS:201038-74-6
- Purity:
- Supply Ability: 10g
- SB-269970
-
- $3500.00
-
2026-05-21
- CAS:201038-74-6
- Purity:
- Supply Ability: 10g
- SB-269970
-
- $4600.00
-
2025-08-22
- CAS:201038-74-6
- Purity:
- Supply Ability: 10g
|
| | SB 269970 hydrochloride Basic information |
| Product Name: | SB 269970 hydrochloride | | Synonyms: | CS-776;SB-269970;SB 269970;SB269970HCl;(2R)-1-[(3-HYDROXYPHENYL)SULFONYL]-2-[2-(4-METHYL-1-PIPERIDINYL)ETHYL]PYRROLIDINE HYDROCHLORIDE;Pyrrolidine, 1-((3-hydroxyphenyl)sulfonyl)-2-(2-(4-methyl-1-piperidinyl)ethyl)-, (R)-;(R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine;(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol;Phenol, 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]- | | CAS: | 201038-74-6 | | MF: | C18H28N2O3S | | MW: | 352.49 | | EINECS: | | | Product Categories: | Serotonin receptor | | Mol File: | 201038-74-6.mol |  |
| | SB 269970 hydrochloride Chemical Properties |
| Boiling point | 512.9±56.0 °C(Predicted) | | density | 1.188 | | storage temp. | Inert atmosphere,2-8°C | | solubility | H2O: 22 mg/mL | | form | solid | | pka | 8.88±0.10(Predicted) | | color | White to off-white |
| | SB 269970 hydrochloride Usage And Synthesis |
| Uses | SB 269970 is a selective and potent SR-7 antagonist. | | Definition | ChEBI: 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]phenol is a sulfonamide. | | Biological Activity | Potent and selective 5-HT 7 receptor antagonist (pK i values are 8.9, 7.2 and 6.0 for 5-HT 7A , 5-HT 5A and 5-HT 1B and < 6.0 for 5-HT 1A , 5-HT 1D , 5-HT 1E , 5-HT 1F , 5-HT 2A , 5-HT 2B , 5-HT 2C , 5-HT 4 and 5-HT 6 receptors respectively). Brain penetrant in vivo . | | in vivo | SB-269970 (3-30 mg/kg; i.p.; once) significantly blocks amphetamine and ketamine-induced hyperactivity[2]. | Animal Model: | Male C57BL6/J mice[2] | | Dosage: | 3, 10, 30 mg/kg | | Administration: | Intraperitoneal injection; once | | Result: | Significantly blocked amphetamine and ketamine-induced hyperactivity. |
| | IC 50 | Human 5-HT7 Receptor: 8.3 (pKi) |
| | SB 269970 hydrochloride Preparation Products And Raw materials |
|